- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04223882
Stress Management in Patients With Coronary Artery Disease
Stress Management in Patients With Coronary Artery Disease: a Randomized Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rio Grande Do Sul
-
Porto Alegre, Rio Grande Do Sul, Brazil, 90620-000
- Marcia Moura Schmidt
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≥ 18 years;
- Patients with CAD - obstruction of one or more epicardial arteries with at least 70% stenosis and / or Left Coronary Trunk (TBI) with at least 50% - measured by catheterization (CATE) and having performed elective PCI
- High stress: above average score for the Brazilian population in the Perceived Stress Scale (PSS-10)
- Signing of the Informed Consent.
Exclusion Criteria:
- Age ≥ 80 years
- Patients with inpatient events (AMI, CABG, stroke)
- Indication of catheterization for valvulopathies or congenital heart disease
- Severe aortic stenosis / Ejection fraction <30%, cardiomyopathy, severe congestive heart disease
- Severe diseases with life expectancy <6 months
- Cognitive or mental difficulties to understand the instrument
- Inability to follow up visits
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group Intervention- Management of stress
Patients in the intervention group will receive usual medical care and more stress management intervention.
Stress management with cognitive behavioral techniques will be implemented one month after hospital discharge in the intervention group.
Group sessions will be held between 6-9 people.
There will be 3 1-hour meetings for 3 weeks.
The intervention will be performed by psychologist.
|
Psychoeducation: Coronary artery disease, Percutaneous Coronary Intervention, traditional risk factors and emotional stress. Stress: physiology, triggers, triad (thinking, emotion, action). Skills training: Identify warning signs - signs and symptoms; Monitoring of irrational automatic thoughts generating alternative interpretations of situations or unrealistic thinking patterns (Dysfunctional Thinking Records Sheet). Self-control for stress management: Assertiveness training, problem solving. Thought-stopping technique, designed for dysfunctional thoughts, such as, "I won't do it," "It won't work." Stress Relief / Control Techniques: Diaphragmatic Breathing: Expansion of the abdomen rather than the chest when breathing. Progressive Muscle Relaxation: Maximize tension and alternately relax the muscles (legs, abdomen, chest, arms and face). |
Active Comparator: Group Control
Patients in the control group will receive usual medical care.
|
outpatient medical appointments
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference in Flow-mediated Dilation in the Brachial Artery in the Base and After the Treatment.
Time Frame: Three months after the first evaluation
|
Inter group difference in flow-mediated dilation in the brachial artery in the baseline and after the treatment (about Three months after the first). Vasodilatation of the endothelium-dependent brachial artery was evaluated by ultrasound using a 3-12 MHz linear transducer. Three images of the basal diameter (BD) of the brachial artery at the end of the diastole were acquired, as well as the mean velocity of the baseline arterial flow, with the linear transducer positioned 5 cm above the antecubital fossa. Subsequently, the sphygmomanometer was placed in the arm and inflated 50 mmHg above baseline systolic blood pressure for five minutes. After that, 3 images of the arterial diameter were acquired up to 80 seconds of the deflation of the cuff (post-occlusion diameter- PD), as well as the average of the arterial flow velocity. Flow-dependent vasodilation responses were expressed as a percentage variation from the baseline brachial diameter (PD-BD/ BD x 100). |
Three months after the first evaluation
|
Collaborators and Investigators
Investigators
- Study Director: Marcia Moura Schmidt, PhD, Instituto de Cardiologia do Rio Grande do Sul
- Principal Investigator: Karine Elisa Schwarzer Schmidt, Instituto de Cardiologia do Rio Grande do Sul
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UP 5648/19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress, Psychological
-
New York State Psychiatric InstituteJohnson & JohnsonCompletedPsychological Stress in PregnancyUnited States
-
Baylor UniversityCompletedAcute Psychological StressUnited States
-
Örebro University, SwedenCompletedPsychological Stress Due to SkydivingSweden
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Amrita Vishwa VidyapeethamAmrita Viswa VidyapeethamCompletedCovid Related Psychological StressIndia
-
Institut de Recherche Biomedicale des ArmeesCompletedPsychological Stresses
-
University of California, San FranciscoNational Institute on Aging (NIA); Penn State University; Harvard UniversityCompletedStress | Depressive Symptoms | Psychological Distress | Psychological Stress | Signs and Symptoms | Psychological | Child MaltreatmentUnited States
-
Penn State UniversityStony Brook University; National Institute on Aging (NIA); Oregon State University and other collaboratorsCompleted
-
Military Academy at ETH ZurichSwiss Armed ForcesCompletedPsychological Stress | Psychological AdaptationSwitzerland
-
Nagoya City UniversityAichi Health Promotion FoundationCompleted
Clinical Trials on Management of Stress
-
Massachusetts General HospitalNational Center for Complementary and Integrative Health (NCCIH)CompletedStress, Psychological | Stress, PhysiologicalUnited States
-
Oslo University HospitalNorwegian Cancer SocietyActive, not recruitingCancer | Stress, PsychologicalNorway
-
Amit SoodCompleted
-
Massachusetts General HospitalThe Children's Tumor FoundationCompletedNeurofibromatosis 2United States
-
University of Colorado, DenverCompleted
-
Massachusetts General HospitalThe Children's Tumor FoundationCompletedNeurofibromatosesUnited States
-
Monash UniversityCompleted
-
Erasmus Medical CenterIndigo Rijnmond, the Netherlands; Avant Sanare, The Netherlands; Erasmus University...UnknownSmoking | Smoking Cessation | Stress | Stress, Psychological | Health Behavior | Smoking, Tobacco | Smoking, CigaretteNetherlands
-
University of South FloridaNational Cancer Institute (NCI)CompletedCancer | Unspecified Adult Solid Tumor, Protocol Specific | Psychological StressUnited States, Puerto Rico
-
University of PittsburghAmerican Cancer Society, Inc.CompletedDepression | StressUnited States